Cargando…
The role of NAFLD in cardiometabolic disease: an update
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world, yet the complex pathogenesis remains to be fully elucidated. The prevalence of NAFLD has risen precipitously in recent years and is now a leading indication for liver transplantation. New waitli...
Autores principales: | Faasse, Sarah, Braun, Hayley, Vos, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811670/ https://www.ncbi.nlm.nih.gov/pubmed/29497497 http://dx.doi.org/10.12688/f1000research.12028.1 |
Ejemplares similares
-
Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update
por: Deng, Chu-Jun, et al.
Publicado: (2022) -
An Update on the Chemokine System in the Development of NAFLD
por: Nagata, Naoto, et al.
Publicado: (2022) -
Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD
por: Song, Ming, et al.
Publicado: (2018) -
Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
por: Shao, Yaodi, et al.
Publicado: (2023) -
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
por: Ohtani, Naoko, et al.
Publicado: (2023)